Xuehao Cui

No ORCID on file · 1 paper in corpus
review 2026
Frontiers in immunology ·doi:10.3389/fimmu.2026.1795144

BACKGROUND: Ovarian cancer remains one of the deadliest gynecologic malignancies. Poor outcomes largely reflect late diagnosis, marked inter- and intratumoral heterogeneity, and variable treatment response. METHODS: This review summarizes …